Key result
Preexisting Coxsackie B4 antibodies fail to prevent respiratory illness despite ~67% lower reinfection rates.
Why the study?
An outbreak of respiratory illness associated with Coxsackie B4 virus in children was observed, but the clinical spectrum and role of preexisting antibodies were not fully characterized.
Observational
No
Coxsackie B4 virus can cause mild respiratory illness in children, with a high rate of subclinical infections and reinfections even in the presence of preexisting antibodies.
Answers are grounded in this paper and cite their sources.
Preexisting antibodies may not protect children from Coxsackie B4 respiratory infection; leaves open questions on humoral immunity and reinfection risk.
An outbreak of respiratory illness in a children's home, associated with Coxsackie B4 infection, occurred in the summer of 1964. The illness was mild, characterized primarily by mild to moderate pharyngitis, fever, and rhinorrhea. The duration of symptoms was 3 to 7 days. No pleurodynia, aseptic meningitis, or other syndromes frequently associated with Coxsackie B4 were noted. An analysis of sera available from both before and after the outbreak showed that all children without preexisting antibody titers (<1:8) had serological evidence of infection following the outbreak; one-third of the children with preexisting antibody titer (≥1:8) also showed evidence of reinfection. The ratio of subclinical to clinical infections was 3.4 to 1. The data also suggest that the presence of preexisting antibodies did not prevent the development of respiratory illness. The high prevalence of Coxsackie B4 antibodies in this group and in other studies is noted and may be related to a broad clinical spectrum with a probable preponderance of minor illnesses and frequent inapparent infections.
No takes yet. Share an insight, caveat, or question.
Ray et al. (1967) conducted an observational in Acute respiratory illness associated with Coxsackie B4 virus. Preexisting Coxsackie B4 antibodies (≥1:8 titer) vs. No preexisting antibodies (<1:8 titer) was evaluated on Serological evidence of infection or reinfection following the outbreak. Preexisting Coxsackie B4 antibodies did not prevent respiratory illness, with 33% of seropositive and 100% of seronegative children showing serological evidence of infection during an outbreak.
Synapse has enriched 10 related papers. Consider them for comparative context: